Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.58
Delayed Data
As of Sep 03
 +0.60 / +0.98%
Today’s Change
52.06
Today|||52-Week Range
71.60
-5.90%
Year-to-Date

Today’s Trading

Previous close60.98
Today’s open61.45
Day’s range61.35 - 62.28
Volume11,777,372
Average volume (3 months)9,316,834
Market cap$100.9B
Dividend yield3.31%
Data as of 4:00pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-57.03%
Earnings growth (this year)+28.25%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+6.23%
P/E ratio47.8
Price/Sales5.28
Price/Book55.71

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.86-1.44%
GSKGlaxoSmithKline-0.02-0.05%
CELGCelgene-1.93-1.61%
NVONovo Nordisk-0.19-0.34%
Data as of 4:14pm ET, 09/03/2015

Financials

Next reporting dateOctober 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$20.0B
Annual profit (last year)$1.8B
Net profit margin8.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers